| 0 | ℹ |
Safety and immunogenicity of an adjuvant-free peptide vaccine targeting IL-17A: Phase 1 randomized controlled trial.
(linkinghub.elsevier.com)
|
iScience 2026-07-21 | #vaccination #immunogenicity #clinical trial #peptide #cytokine |